title: Impact of quality of nuchal translucency measurements on detection rates of trisomies 13 and 18.
abstract: OBJECTIVE
  To determine the relative contribution of nuchal translucency (NT) to the biochemical detection rates of combined screening for trisomies 13 and 18 in two healthcare systems practicing different quality-control systems of nuchal measurement.
  
  
  METHODS
  De-identified data collected from the Fetal Medicine Foundation in the United Kingdom and laboratory data from NTD laboratories in the United States were compared for detection rate and false-positive rate (FPR) for combined trisomies 13 and 18 screening and were subcategorized by biochemical only and biochemistry combined with NT measurement.
  
  
  RESULTS
  US and UK biochemical detection rates were virtually identical: 83% for a FPR of 1.8%. When NT measurement was added, the US rate increased to 88% for a 0.7 FPR, but in the UK the rate increased to 94% for a FPR of 0.3%. The mean NT was 1.69 mm in the US and 2.82 mm in the UK.
  
  
  CONCLUSIONS
  NT measurement as practiced in the UK system with tight quality control significantly increased the detection rate and significantly reduced the FPR of combined screening for trisomies 13 and 18, when compared to the US with apparently less rigid quality control.
authors.affiliation: Department of Obstetrics and Gynecology, Mt. Sinai School of Medicine, New York, NY, USA. evans@compregen.com
authors.forename: Mark I
authors.initials: MI
authors.lastname: Evans
authors.forename: Eugene
authors.initials: E
authors.lastname: Pergament
mesh_terms: D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics*; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics*; D005189:False Positive Reactions; D005260:Female; D005865:Gestational Age; D006801:Humans; D048208:Nuchal Translucency Measurement / Q000706:statistics & numerical data*; D011247:Pregnancy; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis; D011786:Quality Control; D014314:Trisomy / Q000175:diagnosis*; D006113:United Kingdom; D014481:United States
chemical_list: D018997:Chorionic Gonadotropin, beta Subunit, Human; D011266:Pregnancy-Associated Plasma Protein-A